PHARMA FINANCE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
PHARMA FINANCE
NACE 68.310, Real estate agency activities
financial year 2024 compared with 2023filed annual accounts (NBB)
Net result for the year
-€97,554
2023 · -€136,937+€39,384
Equity
€2.2m
2023 · €2.3m-€97,554
Cash
€20,286
2023 · €24,691-€4,405
Balance sheet total
€5.9m
2023 · €6.0m-€144,654
Largest movements
Assets
- Tangible fixed assets -€134,380
down €134,380 (-3.1%), from €4.4m to €4.3m
of which Land and buildings: -€130,592
Equity and liabilities
- Reserves -€97,554
down €97,554 (-4.3%), from €2.3m to €2.2m
Income statement
- Gross operating margin +€28,083
up €28,083 (+23.4%), from €119,785 to €147,868
- Other operating charges -€6,520
down €6,520 (-21.7%), from €29,997 to €23,477
- Depreciation -€2,708
down €2,708 (-1.7%), from €155,968 to €153,260
- Financial charges -€2,084
down €2,084 (-2.9%), from €70,769 to €68,685
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2023
-€136,937
Gross operating margin
+€28,083
Depreciation
+€2,708
Other operating charges
+€6,520
Financial income
-€11
Financial charges
+€2,084
Result 2024
-€97,554
raises the resultlowers the result
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€17,761
Investment
-€18,880
Financing
-€3,286
Cash 2023
€24,691
From operations (derived)
+€17,761
Net result for the year
-€97,554
Depreciation
+€153,260
Receivables within one year
+€5,087
Deferred charges and accrued income
+€782
Trade debts
+€2,752
Tax, wage and social debts
+€204
Other debts
-€44,314
Accrued charges and deferred income
-€2,456
Investment (derived)
-€18,880
Investment in fixed assets (net)
-€18,880
Financing
-€3,286
Debts after one year
+€50,264
Current portion of long-term debt
-€53,550
Cash 2024
€20,286
brings cash intakes cash out
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,022,463 | €5,877,809 | -€144,654 | -2.4% |
| Fixed assets | 21/28 | €5,980,089 | €5,845,710 | -€134,380 | -2.2% |
| Tangible fixed assets | 22/27 | €4,397,764 | €4,263,384 | -€134,380 | -3.1% |
| Land and buildings | 22 | €4,383,976 | €4,253,384 | -€130,592 | -3.0% |
| Plant, machinery and equipment | 23 | €13,788 | €10,001 | -€3,787 | -27.5% |
| Financial fixed assets | 28 | €1,582,325 | €1,582,325 | = | 0.0% |
| Current assets | 29/58 | €42,373 | €32,099 | -€10,274 | -24.2% |
| Amounts receivable within one year | 40/41 | €13,054 | €7,967 | -€5,087 | -39.0% |
| Trade receivables | 40 | €12,941 | €7,463 | -€5,478 | -42.3% |
| Other amounts receivable | 41 | €112 | €504 | +€391 | +348% |
| Cash at bank and in hand | 54/58 | €24,691 | €20,286 | -€4,405 | -17.8% |
| Deferred charges and accrued income | 490/1 | €4,629 | €3,847 | -€782 | -16.9% |
| Total equity and liabilities | 10/49 | €6,022,463 | €5,877,809 | -€144,654 | -2.4% |
| Equity | 10/15 | €2,287,393 | €2,189,839 | -€97,554 | -4.3% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €2,268,793 | €2,171,239 | -€97,554 | -4.3% |
| Distributable reserves | 133 | €2,268,793 | €2,171,239 | -€97,554 | -4.3% |
| Amounts payable | 17/49 | €3,735,070 | €3,687,970 | -€47,100 | -1.3% |
| Amounts payable after more than one year | 17 | €1,317,936 | €1,368,200 | +€50,264 | +3.8% |
| Financial debts | 170/4 | €1,317,936 | €1,368,200 | +€50,264 | +3.8% |
| Amounts payable within one year | 42/48 | €2,398,909 | €2,304,001 | -€94,908 | -4.0% |
| Current portion of amounts payable after more than one year | 42 | €78,948 | €25,398 | -€53,550 | -67.8% |
| Trade debts | 44 | €4,765 | €7,517 | +€2,752 | +57.8% |
| Suppliers | 440/4 | €4,765 | €7,517 | +€2,752 | +57.8% |
| Taxes, remuneration and social security | 45 | €22,757 | €22,962 | +€204 | +0.9% |
| Taxes | 450/3 | €22,757 | €22,962 | +€204 | +0.9% |
| Other amounts payable | 47/48 | €2,292,439 | €2,248,125 | -€44,314 | -1.9% |
| Accrued charges and deferred income | 492/3 | €18,225 | €15,769 | -€2,456 | -13.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €155,968 | €153,260 | -€2,708 | -1.7% |
| Other operating charges | 640/8 | €29,997 | €23,477 | -€6,520 | -21.7% |
| Gross operating margin | 9900 | €119,785 | €147,868 | +€28,083 | +23.4% |
| Operating profit (loss) | 9901 | -€66,180 | -€28,869 | +€37,311 | +56.4% |
| Financial income | 75/76B | €11 | - | -€11 | |
| Recurring financial income | 75 | €11 | - | -€11 | |
| Financial charges | 65/66B | €70,769 | €68,685 | -€2,084 | -2.9% |
| Recurring financial charges | 65 | €70,769 | €68,685 | -€2,084 | -2.9% |
| Profit (loss) for the period before taxes | 9903 | -€136,937 | -€97,554 | +€39,384 | +28.8% |
| Profit (loss) for the period | 9904 | -€136,937 | -€97,554 | +€39,384 | +28.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€136,937 | -€97,554 | +€39,384 | +28.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.